CNE100002XK2
CNE100002XK2
ZHEJIANG AUSUN PHARMACEUTICAL C
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 6.8B EUR | 6.43B EUR | 8.4B EUR | 8.24B EUR |
Enterprise Value | 6.12B EUR | 5.79B EUR | 7.74B EUR | 7.47B EUR |
Valuation Multiples | ||||
Trailing P/E | 74.45x | 148.15x | 119.44x | 88.68x |
Forward P/E | 19.5x | -- | -- | -- |
Price to Sales | 8.73x | 10.46x | 13.32x | 13.1x |
Price to Book | 2.83x | 2.69x | 3.55x | 3.63x |
EV/Revenue | 7.86x | 9.42x | 12.27x | 11.88x |
EV/EBITDA | 41.99x | 126.17x | 76.88x | 60.55x |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -1.56% | -1.59% | -0.58% | -0.27% |